Exosome-mediated drug resistance in cancer: the near future is here.

Simona Taverna, Marco Giallombardo, Riccardo Alessandro, David Hong, Marco Giallombardo, Christian Rolfo

Risultato della ricerca: Article

12 Citazioni (Scopus)

Abstract

Drug resistance exerts a crucial role in several cancer treatments. Understanding the resistance mechanisms against different therapeutic agents can be helpful to determine the prognosis, but remains a tricky task. In this context, tumor- derived exosomes (TDEs) may give crucial answers about these resistance mechanisms. Exosomes are biological nanovesicles with an average size around 30–100 nm of diameter (Figure 1) that originate from the endocytic path- way by the inward budding of multivesicular bod- ies (MVB), and they function as cell-free messengers, involved in the cell–cell communica- tion [Kowal et al. 2014].
Lingua originaleEnglish
Numero di pagine3
RivistaTherapeutic Advances in Medical Oncology
Volume8 (5)
Stato di pubblicazionePublished - 2016

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Entra nei temi di ricerca di 'Exosome-mediated drug resistance in cancer: the near future is here.'. Insieme formano una fingerprint unica.

  • Cita questo